The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robben, P. M.
Right arrow Articles by Sibley, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robben, P. M.
Right arrow Articles by Sibley, L. D.
The Journal of Immunology, 2004, 172: 3686-3694.
Copyright © 2004 by The American Association of Immunologists

Production of IL-12 by Macrophages Infected with Toxoplasma gondii Depends on the Parasite Genotype1

Paul M. Robben*, Dana G. Mordue2,*, Steven M. Truscott{dagger}, Kiyoshi Takeda{ddagger}, Shizuo Akira{ddagger} and L. David Sibley3,*

Departments of * Molecular Microbiology and {dagger} Genetics, Washington University School of Medicine, St. Louis, MO 63110; and {ddagger} Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

Three clonal strain types (I, II, and III) of Toxoplasma gondii predominate worldwide. The outcome of infection in mice is highly dependent on the parasite genotype with type I strains being uniformly virulent, while types II and III are nonvirulent. Interactions with the innate immune response play a major role in determining the outcome of infection in the murine model. To identify key early differences in the innate immune response that contribute to pathogenesis, we examined the cytokine production of macrophages after in vitro infection with parasites of virulent type I and nonvirulent type II genotypes. Infection with type II strain parasites stimulated the production of proinflammatory cytokines, and particularly high levels of the Th1-polarizing cytokine, IL-12. Infection with type II strain parasites stimulated NF-{kappa}B nuclear translocation at early time points and led to the up-regulation of mRNA levels of IL-12 and other proinflammatory cytokines that was dependent on the myeloid differentiation factor 88 signaling pathway. Induction of IL-12 required active invasion by live parasites and was not blocked by infection with virulent type I strain parasites, arguing against an active inhibition of signaling. Our findings suggest that early induction of high levels of IL-12 by macrophages infected with type II strain parasites may contribute to more effective control.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
E. D. Phelps, K. R. Sweeney, and I. J. Blader
Toxoplasma gondii Rhoptry Discharge Correlates with Activation of the Early Growth Response 2 Host Cell Transcription Factor
Infect. Immun., October 1, 2008; 76(10): 4703 - 4712.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. W. Lee, W. Sukhumavasi, and E. Y. Denkers
Phosphoinositide-3-Kinase-Dependent, MyD88-Independent Induction of CC-Type Chemokines Characterizes the Macrophage Response to Toxoplasma gondii Strains with High Virulence
Infect. Immun., December 1, 2007; 75(12): 5788 - 5797.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Debierre-Grockiego, M. A. Campos, N. Azzouz, J. Schmidt, U. Bieker, M. G. Resende, D. S. Mansur, R. Weingart, R. R. Schmidt, D. T. Golenbock, et al.
Activation of TLR2 and TLR4 by Glycosylphosphatidylinositols Derived from Toxoplasma gondii
J. Immunol., July 15, 2007; 179(2): 1129 - 1137.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
V. B. Carruthers and Y. Suzuki
Effects of Toxoplasma gondii Infection on the Brain
Schizophr Bull, May 1, 2007; 33(3): 745 - 751.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-K. Kim, A. E. Fouts, and J. C. Boothroyd
Toxoplasma gondii Dysregulates IFN-{gamma}-Inducible Gene Expression in Human Fibroblasts: Insights from a Genome-Wide Transcriptional Profiling
J. Immunol., April 15, 2007; 178(8): 5154 - 5165.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. P. J. Saeij, J. P. Boyle, S. Coller, S. Taylor, L. D. Sibley, E. T. Brooke-Powell, J. W. Ajioka, and J. C. Boothroyd
Polymorphic Secreted Kinases Are Key Virulence Factors in Toxoplasmosis
Science, December 15, 2006; 314(5806): 1780 - 1783.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Kim, B. A. Butcher, C. W. Lee, S. Uematsu, S. Akira, and E. Y. Denkers
Toxoplasma gondii Genotype Determines MyD88-Dependent Signaling in Infected Macrophages
J. Immunol., August 15, 2006; 177(4): 2584 - 2591.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. E. Molestina and A. P. Sinai
Host and parasite-derived IKK activities direct distinct temporal phases of NF-{kappa}B activation and target gene expression following Toxoplasma gondii infection
J. Cell Sci., December 15, 2005; 118(24): 5785 - 5796.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Shapira, O. S. Harb, J. Margarit, M. Matrajt, J. Han, A. Hoffmann, B. Freedman, M. J. May, D. S. Roos, and C. A. Hunter
Initiation and termination of NF-{kappa}B signaling by the intracellular protozoan parasite Toxoplasma gondii
J. Cell Sci., August 1, 2005; 118(15): 3501 - 3508.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
P. M. Robben, M. LaRegina, W. A. Kuziel, and L. D. Sibley
Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis
J. Exp. Med., June 6, 2005; 201(11): 1761 - 1769.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Kim, L. D. Rio, B. A. Butcher, T. H. Mogensen, S. R. Paludan, R. A. Flavell, and E. Y. Denkers
p38 MAPK Autophosphorylation Drives Macrophage IL-12 Production during Intracellular Infection
J. Immunol., April 1, 2005; 174(7): 4178 - 4184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.